Global /Bangladesh /Healthcare /Drug Manufacturers - General /BXPHARMA
chevron_leftBack
Beximco Pharmaceuticals PLC. logo

Beximco Pharmaceuticals PLC.

BXPHARMA
DSE: BXPHARMA Delayed
114.80BDT 0.7%
0.9360 USD
As of 6 June 2026, Beximco Pharmaceuticals PLC. has a market cap of $417.54M USD, ranking #16370 globally and #14 in Bangladesh. It ranks #1482 in the Healthcare sector, and #537 in the Drug Manufacturers - General industry.
Global Rank
16370
Country Rank
14
Sector Rank
1482
Industry Rank
537
Key Stats
Market Cap
$417.54MUSD
51.21B BDT
Enterprise Value
$477.0MUSD
58.51B BDT
Revenue (TTM)
$377.82MUSD
46.34B BDT
EBITDA (TTM)
$85.66MUSD
10.51B BDT
Net Income (TTM)
$51.8MUSD
6.35B BDT
EBITDA Margin
23%
Profit Margin
14%
PE Ratio
8.1
Forward PE
8.3
PS Ratio
1.1
PB Ratio
1.0
EV/EBITDA
5.5
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Iqbal Ahmed open_in_new
Employees
1,122
Founded
1976
Website
beximcopharma.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
0.7% -2.5% -1.5% -1.8% 0.5% 26%

News

Loading...

Markets

Exchange Ticker Price
Dhaka Stock Exchange
MIC: XDHA
PRIMARY
BXPHARMA
Beximco Pharmaceuticals Ltd
ISIN: BD0453BXPH04
Shares Out.:
446.112M1 Shares Float: 431.766M2
TV:
SA:
YF:
GF:
BA:
MS:
114.80 BDT
London Stock Exchange
MIC: XLON
BXP
Beximco Pharmaceuticals Ltd DR
ISIN: US0885792061
TV:
SA:
YF:
GF:
BA:
BXP
MS:
43 GBX
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Beximco Pharmaceuticals PLC.

Beximco Pharmaceuticals PLC. manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh. The company provides allergic disorder, analgesics and antipyretic, anti-infective, antiviral, cardiovascular, central nervous system, cough and cold, endocrine and diabetes, eye care, gastrointestinal, hormone and steroid, intravenous fluid, musculoskeletal, oncology, respiratory, urogenital, skin care, vitamin and mineral supplement, and other products, as well as contract manufacturing services to other companies. It offers its products in various dosage forms, including solid, liquid, cream and ointment, suppositories, metered dose and dry powder inhaler, nasal spray, sterile, lyophilized injectable, and large volume intravenous fluids. The company also exports its products. Beximco Pharmaceuticals PLC. was incorporated in 1976 and is headquartered in Dhaka, Bangladesh.

Similar Companies

Industry: Drug Manufacturers - General (Bangladesh)
Name
Market Cap diff.
PE
SQURPHARMA
$1.54B
189.43B BDT
270%
7.3
RENATA
$389.85M
47.82B BDT
-6.6%
18.9
UNILEVERCL
$326.4M
40.03B BDT
-22%
55.4
BEACONPHAR
$194.17M
23.82B BDT
-53%
19.2
$145.51M
17.85B BDT
-65%
154.3
$130.77M
16.04B BDT
-69%
6.3
Industry: Drug Manufacturers - General (Global)
Name
Market Cap diff.
PE
LLY
$761.68B
182K%
38.1
JNJ
$547.28B
131K%
26.4
ABBV
$360.63B
86K%
97.4
$324.68B
256.25B CHF
78K%
19.9
AZN
$289.43B
215.59B GBP
69K%
27.6
NOVN
$277.35B
218.9B CHF
66K%
20.5
chevron_leftBack